Oxytocin levels are lower in premenopausal women with type 1 diabetes mellitus compared with matched controls

Diabetes/Metabolism Research and Reviews

Volumn 31, Issue 1, 2015, Pages 102-112

  Kujath, Amber S ^a   Quinn, Lauretta ^b   Elliott, Mary E ^c   Varady, Krista A ^b   Lecaire, Tamara J ^d   Carter, C Sue ^e   Danielson, Kirstie K ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adiposity; Hormonal contraceptives; Oxytocin; Type 1 diabetes

Indexed keywords

CAFFEINE; CONTRACEPTIVE AGENT; ESTROGEN; OXYTOCIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLYCEMIC CONTROL; HEALTH BEHAVIOR; HORMONAL CONTRACEPTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; OBESITY; OXYTOCIN BLOOD LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; REGISTER; REPRODUCTIVE HISTORY; UNITED STATES; WAIST HIP RATIO; WEIGHT GAIN; BLOOD; BODY WEIGHT; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 1; KIDNEY FUNCTION TEST; YOUNG ADULT;

ADULT; BODY WEIGHT; BONE DENSITY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; OXYTOCIN; PREMENOPAUSE; YOUNG ADULT;

EID: 84921062580     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2577     Document Type: Article

References (39)

1. Tom N, Assinder SJ. Oxytocin in health and disease. Int J Biochem Cell Biol 2010; 42(2): 202-205. doi:10.1016/j.biocel.2009.10.008.
2. Lippert TH, Mueck AO, Seeger H, Pfaff A. Effects of oxytocin outside pregnancy. Horm Res 2003; 60(6): 262-271. doi:10.1159/000074243.
3. Zingg HH, Laporte SA. The oxytocin receptor. Trends Endocrinol Metab 2003; 14(5): 222-227. doi:10.1016/s1043-2760(03)00080-8.
4. Deblon N, Veyrat-Durebex C, Bourgoin L, et al.. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One 2011; 6(9): e25565. doi:10.1371/journal.pone.0025565.
5. Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging (Albany NY) 2011; 3(12): 1169-1177.
6. Beranger GE, Pisani DF, Castel J, et al. Oxytocin reverses ovariectomy-induced osteopenia and body fat gain. Endocrinology 2014; 155(4): 1340-1352. doi:10.1210/en.2013-1688.
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36(Suppl 1): S67-74. doi:10.2337/dc13-s067.
8. Fisher BM, Baylis PH, Thornton S, Frier BM. Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin-dependent) diabetes. J Clin Endocrinol Metab 1989; 68(3): 688-692. doi:10.1210/jcem-68-3-688.
9. Paolisso G, Sgambato S, Giugliano D, et al. Effects of oxytocin delivery on counter-regulatory hormone response in insulin-dependent (type 1) diabetic subjects. Horm Res 1989; 31(5-6): 250-255.
10. Zhang H, Wu C, Chen Q, et al. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One 2013; 8(5): e61477. doi:10.1371/journal.pone.0061477.
11. Florian M, Jankowski M, Gutkowska J. Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology 2010; 151(2): 482-91. doi:10.1210/en.2009-0624.
12. Gutkowska J, Broderick TL, Bogdan D, Wang D, Lavoie J, Jankowski M. Downregulation of oxytocin and natriuretic peptides in diabetes: Possible implications in cardiomyopathy. J Physiol (Lond) 2009; 587(Pt 19): 4725-4736. doi:10.1113/jphysiol.209.176461.
13. Borg J, Melander O, Johansson L, Uvnas-Moberg K, Rehfeld JF, Ohlsson B. Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia. BMC Gastroenterol 2009; 9: 17-25. doi:10.1186/1471-230x-9-17.
14. Kontoangelos K, Raptis AE, Papageorgiou CC, et al. Oxytocin and psychological factors affecting type 2 diabetes mellitus. Exp Diabetes Res 2012; 2012: 560864. doi:10.1155/2012/560864.
15. Danielson KK, Elliott ME, LeCaire T, Binkley N, Palta M. Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes. Osteoporos Int 2009; 20(6): 923-933. doi:10.1007/s00198-008-0763-3.
16. Palta M, LeCaire T, Daniels K, Shen G, Allen C, D'Alessio D. Risk factors for hospitalization in a cohort with type 1 diabetes. Wisconsin Diabetes Registry. Am J Epidemiol 1997; 146(8): 627-636.
17. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122(1): 51-65.
18. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985; 121(1): 91-106.
19. Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study. Eur J Endocrinol 2007; 156(5): 555-562. doi:10.1530/eje-06-0753.
20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(4): 977-986. doi:10.1056/nejm199309303291401.
21. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3, 418 individuals with CKD. Am J Kidney Dis 2008; 51(3): 395-406. doi:10.1053/j.ajkd.2007.11.018.
22. Bakermans-Kranenburg MJ, van I Jzendoorn MH. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry 2013; 3: e258. doi:10.1038/tp.2013.34.
23. Berlin KS, Rabideau EM, Hains AA. Empirically derived patterns of perceived stress among youth with type 1 diabetes and relationships to metabolic control. J Pediatr Psychol 2012; 37(9): 990-998. doi:10.1093/jpepsy/jss080.
24. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25(3): 464-470. doi:10.2337/diacare.25.3.464.
25. Lawson EA, Donoho DA, Blum JI, et al. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry 2011; 72(11): 1546-1551. doi:10.4088/jcp.10m06617.
26. Saravia FE, Gonzalez SL, Roig P, Alves V, Homo-Delarche F, De Nicola AF. Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse. Cell Mol Neurobiol 2001; 21(1): 15-27.
27. Beauquis J, Homo-Delarche F, Revsin Y, De Nicola AF, Saravia F. Brain alterations in autoimmune and pharmacological models of diabetes mellitus: focus on hypothalamic-pituitary-adrenocortical axis disturbances. Neuroimmunomodulation 2008; 15(1): 61-67. doi:10.1159/000135625.
28. Olszewski PK, Klockars A, Olszewska AM, Fredriksson R, Schioth HB, Levine AS. Molecular, immunohistochemical, and pharmacological evidence of oxytocin's role as inhibitor of carbohydrate but not fat intake. Endocrinology 2010; 151(10): 4736-4744. doi:10.1210/en.2010-0151.
29. Lawson EA, Holsen LM, Santin M, et al. Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J Clin Endocrinol Metab 2012; 97(10): E1898-908. doi:10.1210/jc.2012-1702.
30. Breuil V, Amri EZ, Panaia-Ferrari P, et al. Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition. Joint Bone Spine 2011; 78(6): 611-615. doi:10.1016/j.jbspin.2011.02.002.
31. Stephenson FA, Rogol AD. Oxytocin: anti-insulin-like effects in isolated fat cells. Arch Biochem Biophys 1984; 234(1): 230-234.
32. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB. Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 2001; 86(3): 1188-1193.
33. Stock S, Karlsson R, von Schoultz B. Serum profiles of oxytocin during oral contraceptive treatment. Gynecol Endocrinol 1994; 8(2): 121-126.
34. Silber M, Almkvist O, Larsson B, Stock S, Uvnas-Moberg K. The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions. Contraception 1987; 36(6): 641-650. doi:10.1016/0010-7824(87)90037-0.
35. Elabd C, Basillais A, Beaupied H, et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells 2008; 26(9): 2399-2407. doi:10.1634/stemcells.208-0127.
36. Tamma R, Colaianni G, Zhu LL, et al. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A 2009; 106(17): 7149-7154. doi:10.1073/pnas.0901890106.
37. Ho JM, Blevins JE. Coming full circle: contributions of central and peripheral oxytocin actions to energy balance. Endocrinology 2013; 154(2): 589-596. doi:10.1210/en.2012-1751.
38. Mennella JA, Pepino MY, Teff KL. Acute alcohol consumption disrupts the hormonal milieu of lactating women. J Clin Endocrinol Metab 2005; 90(4): 1979. doi:10.1210/jc.2004-1593.
39. Dicker SE. Release of vasopressin and oxytocin from isolated pituitary glands of adult and new-born rats. J Physiol 1966; 185(2): 429-444.